MCA
GH icon

MSH Capital Advisors’s Guardant Health GH Stock Holding History

MSH Capital Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
6,242
-39
-0.6% -$4.24K 0.16% 130
2026
Q1 		$580K Sell
6,281
-656
-9% -$65.9K 0.12% 160
2025
Q4 		$709K Sell
6,937
-5,916
-46% -$529K 0.15% 148
2025
Q3 		$803K Hold
12,853
– – 0.22% 117
2025
Q2 		$669K Sell
12,853
-2,270
-15% -$101K 0.19% 126
2025
Q1 		$644K Sell
15,123
-604
-4% -$26.1K 0.2% 120
2024
Q4 		$480K Buy
+15,727
New +$442K 0.15% 156

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MSH Capital Advisors's GH Position: Q2 2026 in Review

MSH Capital Advisors reduced its Guardant Health (GH) stake by 0.62% in Q2 2026, selling an estimated $4.24K and leaving 6,242 shares worth $936K. The position accounts for 0.16% of the portfolio, ranked #130.

MSH Capital Advisors first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • MSH Capital Advisors held 6,242 shares of Guardant Health worth $936K as of Q2 2026.
  • MSH Capital Advisors sold 39 Guardant Health shares in Q2 2026, an estimated $4.24K.
  • Guardant Health made up 0.16% of MSH Capital Advisors's portfolio in Q2 2026, its #130 holding.
  • MSH Capital Advisors first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.